MEDX.SW logo
SIX · MEDX.SWIndustrial - MachineryUpdated Nov 16, 2026

medmix AG P/E ratio

Current valuation, historical context, and peer comparisons.

Current P/E ratio

4350.00×

526.3% abovethe 4-observation annual average

Share price10.44
÷
Earnings per share0.0024

Price and EPS in quote currency. Calculation details

Investors are paying 4350.00 for every 1 of reported earnings per share.

P/E over time

2021 – 2025
Annual P/ESelected-period average 694.51×
3-year average1336.49×2 positive annual observations
5-year average694.51×4 positive annual observations
10-year average694.51×4 positive annual observations
Peer median · TTM13.40×3 peers with positive P/E

Historical P/E ratios

Annual period-end data · 5 observations

MEDX.SW annual P/E history, newest first
Period endP/EChange
Dec 31, 202570.25×N/M
Dec 31, 2024N/MN/M
Dec 31, 20232602.74×+4040.7%
Dec 31, 202262.86×+48.9%
Dec 31, 202142.21×N/M

Change is relative to the preceding observation. N/M values are excluded from averages.

How MEDX.SW compares

Company P/E vs. peer trailing-12-month ratios

P/E comparison with MEDX.SW and provider-selected peers
CompanyP/E ratio
4350.00×
MIKN.SW logo
MIKN.SWMikron Holding AG
9.23×
KOMN.SW logo
KOMN.SWKomax Holding AG
N/M
PMN.SW logo
PMN.SWPhoenix Mecano AG
14.49×
MTG.SW logo
MTG.SWMeier Tobler Group AG
N/M
ARBN.SW logo
ARBN.SWArbonia AG
N/M
METN.SW logo
METN.SWMetall Zug AG
N/M
SWTQ.SW logo
SWTQ.SWSchweiter Technologies AG
N/M
STGN.SW logo
STGN.SWStarrag Group Holding AG
13.40×

Peers are selected by the data provider. Business models and earnings definitions can differ.

Put the numbers in context

What does MEDX.SW’s P/E tell you?

01

Start with its own history

At 4350.00×, MEDX.SW is 526.3% above its 4-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

02

Compare like with like

The median of the 3 positive peer ratios above is 13.40×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.

03

Check what drives earnings

One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.

Keep your research connected

Take MEDX.SW into your spreadsheet

Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.

Explore Wisesheets
Quarterly P/E · latest quarter
=WISE("MEDX.SW", "PE Ratio", "LQ")
LQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data

Sources & calculation methodology

Current P/E

Share price 10.44 ÷ EPS 0.0024 = 4350.00×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 16, 2026; this is not a real-time trading quote.

History & averages

Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.

Data definitions and limitations

The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.

MEDX.SW P/E ratio: common questions

The essentials behind the numbers.

medmix AG's current P/E is 4350.00× based on the quote data last updated Nov 16, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.